Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/225442
Influence of Sex and Diagnosis on Clinical Variables and Neurocognitive Performance in Severe Mental Illness. Results From the PsyCourse Study
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Introduction
Bipolar disorder (BD) and schizophrenia (SZ) are serious mental illnesses (SMI) with overlapping symptoms but distinct differences in onset and course. Sex differences are an area of growing interest in SMI. This study aims to examine potential interactions between sex and diagnosis across a broad range of variables, to compare males and females within SZ and BD, and to investigate sex-specific group differences.
Methods
A total of 1516 individuals were included in a cross-sectional study using baseline data from the multicenter PsyCourse Study, including BD (n = 543), SZ (n = 517), and healthy controls (HC) (n = 456). Sociodemographic characteristics, clinical symptoms, psychosocial functioning, quality of life, neurocognitive performance, and somatic comorbidities were assessed. Generalized linear models were used to analyze differences between groups and sexes. False Discovery Rate (FDR) and Bonferroni post hoc comparisons were performed.
Results
Significant interactions were identified in age (p = 0.001), age at treatment (p = 0.05), illness duration (p = 0.03), illicit drug use (p = 0.01), and smoking (p = 0.05). Differences in substance use were observed across groups and sexes, with the highest rates found in males with SZ. The BD group showed better functioning and neurocognitive performance compared with the SZ group. Within the BD group, females reported better performance in verbal memory (p = 0.003) and psychomotor speed (p < 0.001) than males. Moreover, both females and males with SMI showed higher rates of thyroid alterations compared with HC (p = 0.01 for females and p = 0.002 for males).
Conclusions
Significant sex differences were observed in substance use and somatic comorbidities. Interactions between diagnosis and sex underscore the importance of considering both factors in clinical assessments. These findings highlight the need to tailor sex-specific treatment for each patient. Further research is needed to explore the role of sex hormones and other biological and societal factors in the presentation and course of these disorders.
Matèries (anglès)
Citació
Citació
SERRA NAVARRO, Maria, HEILBRONNER, Maria, SOLÉ CABEZUELO, Brisa, BORRÀS, Roger, MARTÍNEZ-ARÁN, Anabel, ADORJAN, Kristina, NAVARRO FLORES, Alba, KOHSHOUR, Mojtaba oraki, REICH-ERKELENZ, Daniela, SCHULTE, Eva c., SENNER, Fanny, ANGHELESCU, Ion-george, AROLT, Volker, BAUNE, Bernhard t., DANNLOWSKI, Udo, FALLGATTER, Andreas j., FIGGE, Christian, JÄGER, Markus, JUCKEL, Georg, KONRAD, Carsten, DIETRICH, Detlef e., REIMER, Jens, REININGHAUS, Eva z., SCHMAUSS, Max, SCHMITT, Andrea, SPITZER, Carsten, WILTFANG, Jens, ZIMMERMANN, Jorg, PAPIOL, Sergi, HEILBRONNER, Urs, FALKAI, Peter, SCHULZE, Thomas g., VIETA I PASCUAL, Eduard, TORRENT FONT, Carla, BUDDE, Monika, AMORETTI GUADALL, Silvia. Influence of Sex and Diagnosis on Clinical Variables and Neurocognitive Performance in Severe Mental Illness. Results From the PsyCourse Study. _Acta Psychiatrica Scandinavica_. 2025. [consulta: 30 de gener de 2026]. ISSN: 0001-690X. [Disponible a: https://hdl.handle.net/2445/225442]